| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant Treatment of Colorectal Cancer: Towards Tumor-specific Immunotherapies
|
van den Eertwegh, AJM
|
|
2001
|
20 |
1-2 |
p. 101-108
|
artikel
|
| 2 |
Adjuvant Treatment of Colorectal Cancer: Towards Tumor-specific Immunotherapies
|
van den Eertwegh, AJM
|
|
|
20 |
1-2 |
p. 101-108
|
artikel
|
| 3 |
Death Receptor Ligands, in Particular TRAIL, to Overcome Drug Resistance
|
de Jong, S.
|
|
2001
|
20 |
1-2 |
p. 51-56
|
artikel
|
| 4 |
Drug Resistance in Cancer: A Perspective
|
Goldie, James H.
|
|
2001
|
20 |
1-2 |
p. 63-68
|
artikel
|
| 5 |
Drug Resistance in Melanoma: Mechanisms, Apoptosis, and New Potential Therapeutic Targets
|
Grossman, Douglas
|
|
2001
|
20 |
1-2 |
p. 3-11
|
artikel
|
| 6 |
Instructions for Authors
|
|
|
2001
|
20 |
1-2 |
p. 145
|
artikel
|
| 7 |
Intermittent Blood Flow in Solid Tumours – an under-appreciated Source of ‘drug Resistance’
|
Durand, Ralph E.
|
|
2001
|
20 |
1-2 |
p. 57-61
|
artikel
|
| 8 |
Lineage-specific Mechanism of Drug and Radiation Resistance in Melanoma Mediated by Tyrosinase-related Protein 2
|
Pak, Brian J.
|
|
2001
|
20 |
1-2 |
p. 27-32
|
artikel
|
| 9 |
Malignant Cells, Directors of the Malignant Process: Role of Transforming Growth Factor-beta
|
Teicher, Beverly A.
|
|
2001
|
20 |
1-2 |
p. 133-143
|
artikel
|
| 10 |
Mechanisms Associated with cell Adhesion Mediated Drug Resistance (CAM-DR) in Hematopoietic Malignancies
|
Hazlehurst, Lori A.
|
|
2001
|
20 |
1-2 |
p. 43-50
|
artikel
|
| 11 |
Molecular and Physiologic Mechanisms of Drug Resistance in Cancer: An Overview
|
Kerbel, R.S.
|
|
2001
|
20 |
1-2 |
p. 1-2
|
artikel
|
| 12 |
Multidrug Resistance in Brain Tumors: Roles of the Blood–brain Barrier
|
Régina, Anthony
|
|
2001
|
20 |
1-2 |
p. 13-25
|
artikel
|
| 13 |
Possible Mechanisms of Acquired Resistance to Anti-angiogenic Drugs: Implications for the Use of Combination Therapy Approaches
|
Kerbel, Robert S.
|
|
2001
|
20 |
1-2 |
p. 79-86
|
artikel
|
| 14 |
Prospects for Targeting Protein Kinase C Isozymes in the Therapy of Drug-resistant Cancer – An Evolving Story
|
O'Brian, Catherine A.
|
|
2001
|
20 |
1-2 |
p. 95-100
|
artikel
|
| 15 |
Resistance to Rapamycin: A Novel Anticancer Drug
|
Huang, Shile
|
|
2001
|
20 |
1-2 |
p. 69-78
|
artikel
|
| 16 |
Targeting Molecular Signals in Chk1 Pathways as a New Approach for Overcoming Drug Resistance
|
Hapke, Gunnar
|
|
2001
|
20 |
1-2 |
p. 109-115
|
artikel
|
| 17 |
The Challenge of Pathway and Environment-mediated Drug Resistance
|
Sausville, Edward A.
|
|
2001
|
20 |
1-2 |
p. 117-122
|
artikel
|
| 18 |
The Role for Liposomal Drug Delivery in Molecular and Pharmacological Strategies to Overcome Multidrug Resistance
|
Mayer, Lawrence D.
|
|
2001
|
20 |
1-2 |
p. 87-93
|
artikel
|
| 19 |
Translational Regulation as a Novel Mechanism for the Development of Cellular Drug Resistance
|
Schmitz, John C.
|
|
2001
|
20 |
1-2 |
p. 33-41
|
artikel
|
| 20 |
Tumor Physiology and Drug Resistance
|
Tannock, Ian F.
|
|
2001
|
20 |
1-2 |
p. 123-132
|
artikel
|
Tijdschrift beschrijving